Max deletion destabilizes MYC protein and abrogates Eμ-Myc lymphomagenesis
H. Mathsyaraja, B. Freie, P.-F. Cheng, E. Babaeva, D. Janssens, S. Henikoff, R. N. Eisenman
Abstract
Although MAX is widely regarded as an obligate dimerization partner for MYC, its function in normal development and neoplasia is not well defined. We show that B-cell specific deletion of Max has a surprisingly modest effect on B-cell development but completely abrogates E{micro}-Myc driven lymphomagenesis. In both contexts, MAX loss leads to a significant reduction in MYC protein levels. This outcome is associated with the downregulation of numerous transcriptional targets of MAX including a subset that regulate MYC stability. Reduction in MYC protein levels is also observed in multiple cell lines treated with a MYC-MAX dimerization inhibitor. Our work uncovers a layer of Myc autoregulation critical for lymphomagenesis yet partly dispensable for normal lymphoid development.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- An early Myc-dependent transcriptional program underlies enhanced macromolecular biosynthesis and cell growth during B-cell activation
A. Tesi, S. De Pretis, … A. Sabo·bioRxiv·Mar 4, 2019
- Differential transcriptional reprogramming by wild type and lymphoma-associated mutant MYC proteins as B-cells convert to lymphoma-like cells
A. Mahani, G. Arvidsson, … A. P. Wright·bioRxiv·Jul 13, 2020
- Deletion of the transcriptional regulator TFAP4 accelerates c-MYC-driven lymphomagenesis
M. Herold, M. A. Potts, … A. Strasser·Cell Death & DifferentiationPeer-reviewed·Jun 1, 2023
- Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition
R. Winkler, A.-S. Mägdefrau, … C. Kosan·OncogenePeer-reviewed·Sep 6, 2022
- The MYC antagonist MNT autoregulates its expression and supports proliferation in MAX deficient cells
M Carmen Lafita-Navarro, Judit Liaño-Pons, … Javier León·bioRxiv·Nov 24, 2017
- MNT loss in MYC-driven B lymphoma cells enhances apoptosis, inhibits proliferation and increases sensitivity to cancer drugs.
Hai Vu Nguyen, Marcel Michla, … Suzanne Cory·bioRxiv·May 1, 2026